| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_47c757b23cbbb06df098716ddf81eb48 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-27 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-325
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 |
| filingDate |
2000-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae9fa53fe8f84edd4832b73ec38df895
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea894380f8c5971975a72692f6436831
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26d2d07364071b87c8afe87f52460c2f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fab88c8497960cf56c278acefe3a5174
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed64ee9821e400b7142ce0b547725389 |
| publicationDate |
2005-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
YU-20302-A |
| titleOfInvention |
THE USE OF RETIGABIN IN THE TREATMENT OF NEUROPATHIC PAIN |
| abstract |
The present invention relates to the use of 2-amino-4- (4-fluorobenzylamino) -1-ethoxycarbonylaminobenzene of formula I (international generic name: retigabine) or its pharmaceutically usable salts for the manufacture of pharmaceutical products for the prophylaxis and treatment of neuropathic pain. to 2-amino-4- (4-fluorobenzylamino) -1-ethoxycarbonylaminobenzenes of the formula (I) or the pharmaceutically applicable salts of said compounds for the prophylaxis and treatment of neuropathic pain. |
| priorityDate |
1999-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |